Citation Impact
Citing Papers
AZ 242, a novel PPARα/γ agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats
2002
Thiazolidinediones
2004 Standout
PET Study of D1 Dopamine Receptor Binding in Neuroleptic-Naive Patients With Schizophrenia
2002
Pharmacophore modeling and parallel screening for PPAR ligands
2007
In vivo striatal binding of the D1 antagonist SCH 23390 is not modified by changes in dopaminergic transmission
1996
Inflammation and metabolic disorders
2006 StandoutNature
Structure‐Based Pharmacophore Screening for Natural‐Product‐Derived PPARγ Agonists
2008
Pomegranate and its Many Functional Components as Related to Human Health: A Review
2010 Standout
From magic bullets to designed multiple ligands
2004
Ghrelin?a hormone with multiple functions
2004
Synthesis and structure–activity relationship of 1,2,4-triazole-containing diarylpyrazolyl carboxamide as CB1 cannabinoid receptor–ligand
2009
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
2014 Standout
Minireview: Lipid Metabolism, Metabolic Diseases, and Peroxisome Proliferator-Activated Receptors
2003
Effects of the substituted (S)-3-phenylpiperidine (−)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains
1999 StandoutNobel
Sphingosine 1-phosphate and lysophosphatidic acid receptors: agonist and antagonist binding and progress toward development of receptor-specific ligands
2004
Curcumin as “Curecumin”: From kitchen to clinic
2007 Standout
4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARα/γ agonists. Part I: Synthesis and pharmacological evaluation
2008
Inflammation, stress, and diabetes
2005 Standout
Peroxisome proliferator-activated receptor structures: Ligand specificity, molecular switch and interactions with regulators
2007
4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARα/γ agonists. Part. II: Synthesis and pharmacological evaluation of oxime and acidic head group structural variations
2009
A neuropsychological theory of positive affect and its influence on cognition.
1999 Standout
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
Short Sleep Duration Is Associated with Reduced Leptin, Elevated Ghrelin, and Increased Body Mass Index
2004 Standout
Pomegranate flower: a unique traditional antidiabetic medicine with dual PPAR‐α/‐γ activator properties
2007
Glycaemic control in type 2 diabetes: Targets and new therapies
2009
Peroxisome Proliferator-Activated Receptors and Atherogenesis
2004
3d Transition Metals for C–H Activation
2018 Standout
Microwave-Assisted Cp*CoIII-Catalyzed C–H Activation/Double C–N Bond Formation Reactions to Thiadiazine 1-Oxides
2017
A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine
2005 Standout
PPARα/γ ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly
2003
Indol-1-yl Acetic Acids as Peroxisome Proliferator-Activated Receptor Agonists: Design, Synthesis, Structural Biology, and Molecular Docking Studies
2006
Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States
2006 Standout
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Green synthesis of zinc oxide nanoparticles using Hibiscus subdariffa leaf extract: effect of temperature on synthesis, anti-bacterial activity and anti-diabetic activity
2014 Standout
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Growth Hormone Doping in Sports: A Critical Review of Use and Detection Strategies
2012
D1- Versus D2-Receptor Modulation of Visuospatial Working Memory in Humans
1998
Biological importance of the indole nucleus in recent years: A comprehensive review
2010 Standout
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
1998 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Physiology of Microglia
2011 Standout
Works of Lars Ynddal being referenced
The pharmacokinetics, pharmacodynamics, safety and tolerability following 7 days daily oral treatment with NN703 in healthy male subjects
2001
The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers
2000
Oral administration of NNC 756 — a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man
1995
Novel Tricyclic-α-alkyloxyphenylpropionic Acids: Dual PPARα/γ Agonists with Hypolipidemic and Antidiabetic Activity
2002
New 3-Alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-Dioxide Derivatives Activate ATP-Sensitive Potassium Channels of Pancreatic Beta Cells
2006
Human Glucagon Receptor Antagonists with Thiazole Cores. A Novel Series with Superior Pharmacokinetic Properties
2009
Large Dimeric Ligands with Favorable Pharmacokinetic Properties and Peroxisome Proliferator-Activated Receptor Agonist Activity in Vitro and in Vivo
2003